Law channel feed – Endpoints News

Law channel feed

GSK to SCOTUS: Don't take up 'skinny' generic drug label case

3 years ago

Fewer than 40% of new accelerated approvals demonstrate 'high' therapeutic value, study says

3 years ago

Endo loses Vasostrict patent battle as sales take a hit from generics

3 years ago

New Jersey judge decides Bausch Health's Xifaxan is 'prior art,' does not infringe Curia patents

3 years ago

Endo files for Chapter 11 as it looks to finish off its opioid litigation

3 years ago

President Biden signs major drug pricing reforms into law: What's coming for biopharma?

3 years ago

Zantac litigation: One suit down, many more to go, GSK says

3 years ago

AstraZeneca files lawsuit against former exec as he jumps to GSK

3 years ago

French pharma exec says he lied to FDA in attempt to steal a Novartis weight loss drug

3 years ago

House passes historic drug pricing reforms, lining up decades-in-the-making win for Biden and Democrats

3 years ago

Senate Finance chair continues his investigation into pharma taxes with requests for Amgen

3 years ago

Paving the way for Merck's buyout, Seagen loses arbitration dispute with Daiichi Sankyo over ADC tech

3 years ago

Blasting 'speculative commentary,' GSK offers update on Zantac litigation and vows to 'vigorously defend itself'

3 years ago

Sanofi, GSK, Haleon see stock prices dip and dive amid litigation for recalled heartburn drug

3 years ago

Major drug price reforms head for Biden's signature as PhRMA weighs legal options

3 years ago

Faced with thousands of opioid lawsuits, Endo says it will likely file for bankruptcy 'imminently'

3 years ago

With drug pricing almost done, Congress looks to wrap up FDA user fee legislation

3 years ago

Senate Dems cling to a simple majority to pass some of the biggest drug pricing reforms ever

3 years ago

Prosecutors fail to extend ex-GSK scientists' sentences in trade secrets case

3 years ago

'What’s wrong with having lots of patents?' Federal appeals judge sides with AbbVie in Humira case

3 years ago

AbbVie's Allergan inks $2.3B+ opioid settlement with several states

3 years ago

Bausch Health asserts push to 'vigorously' defend Xifaxan patent litigation

3 years ago

Which drugs may be hit with negotiations if the reconciliation bill passes? Wall St. analysts explain

3 years ago

Manchin strikes again: Reconciliation package surfaces, with drug pricing reforms fully intact — for now

3 years ago

First page Previous page 30 31 323334 35 36 Next page Last page